Cite

HARVARD Citation

    Fusco, M. et al. (2021). Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With BRAF V600E-Mutated Gliomas. Cancer control. p. . [Online]. 
  
Back to record